The board of directors of AegirBio has now received the results of the internal investigation concerning the company's distributor, which was carried out by external parties. As a consequence hereof, AegirBio terminates the distribution agreement with NowMed Sweden AB. AegirBio is taking control over the company's distribution in Asia until an agreement is signed with a new distributor. NowMed Sweden AB is working on transferring all purchase orders from the local distributor to AegirBio, including the purchase order that has already been sent to Thailand. AegirBio is now establishing a direct line of contact with the local distributor of the pre-existing purchase orders in Thailand to secure the volumes, destinations, call-offs on purchase orders and time of delivery. It is also Aegirbio's intention to hire a regional consultant to further monitor the company's interests in Asia. AegirBio is also, with immediate effect, taking control of the current business in Sweden as well as the contact with potential customers in and outside of Sweden.